| scholarly article | Q13442814 |
| P2093 | author name string | Francois Berthiaume | |
| Mehmet A. Orman | |||
| Marianthi G. Ierapetritou | |||
| Ioannis P. Androulakis | |||
| P2860 | cites work | Computational prediction of human metabolic pathways from the complete human genome | Q21092879 |
| An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR) | Q21194867 | ||
| The ENZYME database in 2000 | Q22242849 | ||
| KEGG: kyoto encyclopedia of genes and genomes | Q24515297 | ||
| Expansion of the BioCyc collection of pathway/genome databases to 160 genomes | Q24535096 | ||
| BRENDA, enzyme data and metabolic information | Q24548428 | ||
| UniProt: the Universal Protein knowledgebase | Q24598826 | ||
| Global reconstruction of the human metabolic network based on genomic and bibliomic data | Q24677060 | ||
| Network-based analysis of metabolic regulation in the human red blood cell | Q28212164 | ||
| Analysis of optimality in natural and perturbed metabolic networks | Q28213254 | ||
| The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase | Q28373346 | ||
| Metabolic flux analysis of mitochondrial uncoupling in 3T3-L1 adipocytes | Q28476081 | ||
| Regulatory on/off minimization of metabolic flux changes after genetic perturbations | Q28769658 | ||
| A rational design approach for amino acid supplementation in hepatocyte culture | Q29392880 | ||
| Escherichia coli K-12 undergoes adaptive evolution to achieve in silico predicted optimal growth | Q29397612 | ||
| In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data | Q29618471 | ||
| Dynamic analysis of integrated signaling, metabolic, and regulatory networks | Q30441717 | ||
| Compartmentalization of the Edinburgh Human Metabolic Network | Q30986319 | ||
| Flux-balance analysis of mitochondrial energy metabolism: consequences of systemic stoichiometric constraints | Q31920157 | ||
| Metabolic flux analysis of CHO cell metabolism in the late non-growth phase. | Q51772488 | ||
| Maximum entropy decomposition of flux distribution at steady state to elementary modes | Q51782351 | ||
| A metabolic control analysis of kinetic controls in ATP free energy metabolism in contracting skeletal muscle | Q52075316 | ||
| Metabolite-balancing techniques vs. 13C tracer experiments to determine metabolic fluxes in hybridoma cells | Q52219118 | ||
| Stoichiometric analysis of animal cell growth and its application in medium design | Q52377312 | ||
| Network analysis of intermediary metabolism using linear optimization. I. Development of mathematical formalism | Q52425486 | ||
| Mathematical analysis of isotope labeling in the citric acid cycle with applications to 13C NMR studies in perfused rat hearts | Q52700131 | ||
| What Controls Glycolysis in Bloodstream FormTrypanosoma brucei? | Q57393902 | ||
| Triosephosphate isomerase deficiency: predictions and facts | Q71835515 | ||
| Calculation of absolute metabolic flux and the elucidation of the pathways of glutamate labeling in perfused rat heart by 13C NMR spectroscopy and nonlinear least squares analysis | Q72149299 | ||
| Use of mathematical models for predicting the metabolic effect of large-scale enzyme activity alterations. Application to enzyme deficiencies of red blood cells | Q72221379 | ||
| Mass flux balance-based model and metabolic flux analysis for collagen synthesis in the fibrogenesis process of human liver | Q73047111 | ||
| Multiple steady states with distinct cellular metabolism in continuous culture of mammalian cells | Q73226783 | ||
| Metabolic flux analysis of postburn hepatic hypermetabolism | Q73306352 | ||
| A universal framework for 13C metabolic flux analysis | Q74227987 | ||
| Fluxes and enzyme activities in central metabolism of myeloma cells grown in chemostat culture | Q74660098 | ||
| Metabolism of peptide amino acids by Chinese hamster ovary cells grown in a complex medium | Q74660866 | ||
| Control of oxidative phosphorylation, gluconeogenesis, ureagenesis and ATP turnover in isolated perfused rat liver analyzed by top-down metabolic control analysis | Q74750994 | ||
| High cell density and high monoclonal antibody production through medium design and rational control in a bioreactor | Q81646856 | ||
| Energy metabolism and ATP balance in animal cell cultivation using a stoichiometrically based reaction network | Q81647024 | ||
| Network-based prediction of human tissue-specific metabolism | Q81798711 | ||
| Genome-scale modeling and in silico analysis of mouse cell metabolic network | Q82298733 | ||
| Metabolic flux analysis of hepatocyte function in hormone- and amino acid-supplemented plasma | Q44442836 | ||
| Profiling of dynamic changes in hypermetabolic livers | Q44473969 | ||
| A critical perspective of the use of (13)C-isotopomer analysis by GCMS and NMR as applied to cardiac metabolism. | Q44735612 | ||
| Estimation of metabolic flux from dominant rate constants in vivo: application to brain and heart | Q44735616 | ||
| Quantitative effects of thermal injury and insulin on the metabolism of the skeletal muscle using the perfused rat hindquarter preparation | Q45095296 | ||
| Thermodynamic-based computational profiling of cellular regulatory control in hepatocyte metabolism | Q45126764 | ||
| Mechanistic model of cardiac energy metabolism predicts localization of glycolysis to cytosolic subdomain during ischemia | Q45244970 | ||
| Enhanced antibody production following intermediate addition based on flux analysis in mammalian cell continuous culture. | Q45933148 | ||
| Quantification of statin effects on hepatic cholesterol synthesis by transient (13)C-flux analysis. | Q45952866 | ||
| Reconstructing metabolic flux vectors from extreme pathways: defining the alpha-spectrum | Q46083927 | ||
| Evolution of intrahepatic carbon, nitrogen, and energy metabolism in a D-galactosamine-induced rat liver failure model | Q46395411 | ||
| Effects of dehydroepiandrosterone administration on rat hepatic metabolism following thermal injury | Q46481025 | ||
| Novel quantitative tools for engineering analysis of hepatocyte cultures in bioartificial liver systems | Q46717379 | ||
| Analysis of cellular metabolism of hybridoma cells at distinct physiological states | Q46760109 | ||
| Monte Carlo sampling can be used to determine the size and shape of the steady-state flux space | Q47417801 | ||
| On the reconstruction of the Mus musculus genome-scale metabolic network model. | Q47853955 | ||
| Material balance studies on animal cell metabolism using a stoichiometrically based reaction network | Q47863148 | ||
| Stirred vessel cultures of rat brain cells aggregates: characterization of major metabolic pathways and cell population dynamics | Q48106403 | ||
| Modular decomposition of metabolic reaction networks based on flux analysis and pathway projection | Q48391295 | ||
| A quadratic programming approach for decomposing steady-state metabolic flux distributions onto elementary modes | Q48472250 | ||
| Analysis of enzymopathies in the human red blood cells by constraint-based stoichiometric modeling approaches | Q50720638 | ||
| Integrated energy and flux balance based multiobjective framework for large-scale metabolic networks | Q51036122 | ||
| An interval approach for dealing with flux distributions and elementary modes activity patterns. | Q51066980 | ||
| Identification of flux regulation coefficients from elementary flux modes: A systems biology tool for analysis of metabolic networks | Q51082383 | ||
| Investigation of metabolic objectives in cultured hepatocytes | Q51114910 | ||
| Identification of distributed metabolic objectives in the hypermetabolic liver by flux and energy balance analysis | Q51320677 | ||
| Effects of glucose and insulin on HepG2-C3A cell metabolism | Q39699721 | ||
| Bayesian flux balance analysis applied to a skeletal muscle metabolic model. | Q39776363 | ||
| Effects of drugs in subtoxic concentrations on the metabolic fluxes in human hepatoma cell line Hep G2. | Q39824671 | ||
| Metabolic flux model for an anchorage-dependent MDCK cell line: characteristic growth phases and minimum substrate consumption flux distribution | Q39958457 | ||
| Comparison of metabolic flux distributions for MDCK cell growth in glutamine- and pyruvate-containing media. | Q40021479 | ||
| Identification of metabolic fluxes in hepatic cells from transient 13C-labeling experiments: Part II. Flux estimation | Q40032706 | ||
| Metabolic pathway analysis of enzyme-deficient human red blood cells. | Q40466616 | ||
| Metabolic-flux analysis of continuously cultured hybridoma cells using (13)CO(2) mass spectrometry in combination with (13)C-lactate nuclear magnetic resonance spectroscopy and metabolite balancing | Q40787464 | ||
| 293SF metabolic flux analysis during cell growth and infection with an adenoviral vector | Q40850016 | ||
| Metabolic flux analysis of hybridoma continuous culture steady state multiplicity | Q40943461 | ||
| Effects of glutamine supply on growth and metabolism of mammalian cells in chemostat culture | Q41110808 | ||
| Intracellular flux analysis in hybridomas using mass balances and in vitro (13)C nmr. | Q41368397 | ||
| Elementary metabolite units (EMU): a novel framework for modeling isotopic distributions | Q41374953 | ||
| Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies | Q41468734 | ||
| Metabolic engineering and human disease | Q41496325 | ||
| Applications of improved stoichiometric model in medium design and fed-batch cultivation of animal cells in bioreactor | Q41505054 | ||
| Metabolic flux determination in C6 glioma cells using carbon-13 distribution upon [1-13C]glucose incubation | Q41525126 | ||
| Network analysis of intermediary metabolism using linear optimization. II. Interpretation of hybridoma cell metabolism | Q41639252 | ||
| Theory for the systemic definition of metabolic pathways and their use in interpreting metabolic function from a pathway-oriented perspective | Q41724911 | ||
| Soft constraints-based multiobjective framework for flux balance analysis | Q41828147 | ||
| Pathway analysis of liver metabolism under stressed condition | Q41833487 | ||
| Computational reconstruction of tissue‐specific metabolic models: application to human liver metabolism | Q41846171 | ||
| Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts | Q41906203 | ||
| Metabolic-flux analysis of hybridoma cells under oxidative and reductive stress using mass balances | Q42326931 | ||
| Modeling hybridoma cell metabolism using a generic genome-scale metabolic model of Mus musculus | Q42657070 | ||
| Flux profile and modularity analysis of time-dependent metabolic changes of de novo adipocyte formation | Q42831228 | ||
| Effects of amino acid transport limitations on cultured hepatocytes | Q42913539 | ||
| Metabolic flux determination in perfused livers by mass balance analysis: effect of fasting | Q42956835 | ||
| Transcriptional and metabolic flux profiling of triadimefon effects on cultured hepatocytes | Q42957799 | ||
| Tissue variation in the control of oxidative phosphorylation: implication for mitochondrial diseases | Q42996199 | ||
| Metabolic flux analysis of CHO cells in perfusion culture by metabolite balancing and 2D [13C, 1H] COSY NMR spectroscopy | Q43246624 | ||
| From fluxes and isotope labeling patterns towards in silico cells | Q43421305 | ||
| Intrahepatic amino acid and glucose metabolism in a D-galactosamine-induced rat liver failure model | Q43693286 | ||
| The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study | Q43698055 | ||
| Flux balance analysis of biological systems: applications and challenges. | Q43740877 | ||
| Glutamate-loading stimulates metabolic flux and improves cell recovery following chemical hypoxia in isolated cardiomyocytes. | Q43816855 | ||
| Analysis of CHO cells metabolic redistribution in a glutamate-based defined medium in continuous culture. | Q43817062 | ||
| Cardiac carbohydrate metabolism in Zucker diabetic fatty rats | Q44026484 | ||
| Metabolic flux analysis of cultured hepatocytes exposed to plasma | Q44217005 | ||
| Metabolic screening of mammalian cell cultures using well-plates | Q44305861 | ||
| Application of multivariate analysis to optimize function of cultured hepatocytes | Q44390363 | ||
| Network-level analysis of metabolic regulation in the human red blood cell using random sampling and singular value decomposition | Q33236264 | ||
| Quantitative elementary mode analysis of metabolic pathways: the example of yeast glycolysis | Q33238510 | ||
| The topology of metabolic isotope labeling networks | Q33295450 | ||
| A procedure for the estimation over time of metabolic fluxes in scenarios where measurements are uncertain and/or insufficient | Q33304395 | ||
| Reconstruction of metabolic pathways for the cattle genome | Q33417923 | ||
| Nontargeted elucidation of metabolic pathways using stable-isotope tracers and mass spectrometry | Q33626814 | ||
| Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy | Q33675261 | ||
| A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1. | Q33722800 | ||
| Advances in flux balance analysis | Q33973453 | ||
| Kinetic analysis of dynamic 13C NMR spectra: metabolic flux, regulation, and compartmentation in hearts | Q34047635 | ||
| 13C metabolic flux analysis | Q34084355 | ||
| Regulation of Gene Expression in Flux Balance Models of Metabolism | Q34101809 | ||
| Transcriptional regulation in constraints-based metabolic models of Escherichia coli | Q34128076 | ||
| Extreme pathway analysis of human red blood cell metabolism | Q34178460 | ||
| HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology | Q34240836 | ||
| Assessment of Metabolic Phenotypes in Patients with Non-ischemic Dilated Cardiomyopathy Undergoing Cardiac Resynchronization Therapy | Q34361776 | ||
| Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells | Q34517790 | ||
| Metabolic control analysis in drug discovery and disease | Q34550535 | ||
| Delineation of substrate selection and anaplerosis in tricarboxylic acid cycle of the heart by 13C NMR spectroscopy and mass spectrometry. | Q34911991 | ||
| Two approaches for metabolic pathway analysis? | Q35062587 | ||
| Metabolic response of perfused livers to various oxygenation conditions | Q35349814 | ||
| Contribution of gene expression to metabolic fluxes in hypermetabolic livers induced through burn injury and cecal ligation and puncture in rats | Q35429254 | ||
| In situ metabolic flux analysis to quantify the liver metabolic response to experimental burn injury | Q35751814 | ||
| The Edinburgh human metabolic network reconstruction and its functional analysis | Q36052649 | ||
| Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single- and double-deletion mutants | Q36217271 | ||
| Predicting metabolic biomarkers of human inborn errors of metabolism | Q37196179 | ||
| Elementary mode analysis: a useful metabolic pathway analysis tool for characterizing cellular metabolism | Q37328003 | ||
| MouseCyc: a curated biochemical pathways database for the laboratory mouse | Q37350831 | ||
| Impact of perturbed pyruvate metabolism on adipocyte triglyceride accumulation | Q37438291 | ||
| Effect of anaplerotic fluxes and amino acid availability on hepatic lipoapoptosis | Q37446190 | ||
| Metabolic flux analysis in mammalian cell culture | Q37615599 | ||
| Metabolic flux analysis in eukaryotes | Q37694051 | ||
| 13C metabolic flux analysis in complex systems | Q37787585 | ||
| Genome‐scale metabolic networks | Q37787963 | ||
| Metabolic flux analysis of embryonic stem cells using three distinct differentiation protocols and comparison to gene expression patterns. | Q39644329 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolic pathway | Q68685 |
| stoichiometry | Q213185 | ||
| metabolic network | Q2263094 | ||
| P304 | page(s) | 511-534 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Critical Reviews in Biomedical Engineering | Q5186662 |
| P1476 | title | Advanced stoichiometric analysis of metabolic networks of mammalian systems | |
| Advanced Stoichiometric Analysis of Metabolic Networks of Mammalian Systems | |||
| P478 | volume | 39 |
| Q26772884 | Amino acids in the cultivation of mammalian cells |
| Q38637370 | Bioengineering solutions for manufacturing challenges in CAR T cells. |
| Q51590229 | Identification of active elementary flux modes in mitochondria using selectively permeabilized CHO cells. |
| Q31126202 | Identification of growth phases and influencing factors in cultivations with AGE1.HN cells using set-based methods |
| Q39082176 | Long-term maintenance of HepaRG cells in serum-free conditions and application in a repeated dose study. |
| Q52691899 | Metabolic flexibility as an adaptation to energy resources and requirements in health and disease |
| Q38058685 | Perspectives in Metabolic Engineering: Understanding Cellular Regulation Towards the Control of Metabolic Routes |
| Q39216749 | Quality by control: Towards model predictive control of mammalian cell culture bioprocesses. |
| Q40778167 | Reconstruction and validation of a constraint-based metabolic network model for bone marrow-derived mesenchymal stem cells |
| Q34903798 | Resuscitation of Ischemic Donor Livers with Normothermic Machine Perfusion: A Metabolic Flux Analysis of Treatment in Rats |
| Q37198583 | Towards high resolution analysis of metabolic flux in cells and tissues |
| Q38595074 | Understanding the cancer cell phenotype beyond the limitations of current omics analyses |
Search more.